Enrolling
A Study of LY3841136 in Japanese Participants With Obesity or Overweight
J3R-JE-YDAB - ClinicalTrials.gov - NCT06297616
The main purpose of this study is to learn about the side effects of LY3841136 when given to Japanese participants with obese or overweight.
Trial Summary
Age Range
18 - 65 yearsConditions the trial is for
ObesityWhat the trial is testing?
LY3841136Could I receive a Placebo?
YesEnrollment Goal
70Trial Dates
Apr 15, 2024 - Dec 2025How long will I be in the trial?
The study will last about 28 weeks and may include up to 17 visits.Trial Phase
IKey Requirements
Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.Participants Must:
Have overweight or obesity
Have had a stable weight for the 3 months before starting the study
Participants Must Not:
Have Type 1 or Type 2 diabetes
Have or are planning a surgical treatment for weight loss
Have been taking or plan to take drugs for weight loss within 3 months prior to starting the study
Lilly Trial Alerts
Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.
Clinical Trial Resources
You will complete the questionnaire on another website.YesNo